DOCSLIB.ORG

Identification of Virus-Encoded Micrornas in Divergent Papillomaviruses

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification of Virus-Encoded Micrornas in Divergent Papillomaviruses RESEARCH ARTICLE Identification of virus-encoded microRNAs in divergent Papillomaviruses Rachel Chirayil1³, Rodney P. Kincaid1³, Christine Dahlke2³, Chad V. Kuny1³, Nicole DaÈlken2, Michael Spohn2, Becki Lawson3, Adam Grundhoff2*, Christopher S. Sullivan1* 1 Center for Systems and Synthetic Biology, Center for Infectious Disease and Dept. Molecular Biosciences, The University of Texas at Austin, Austin, TX, United States of America, 2 Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany, 3 Institute of Zoology, Zoological Society of London, London, United Kingdom a1111111111 a1111111111 ³ These authors share first authorship on this work. a1111111111 * [email protected] (AG); [email protected] (CSS) a1111111111 a1111111111 Abstract MicroRNAs (miRNAs) are small RNAs that regulate diverse biological processes including multiple aspects of the host-pathogen interface. Consequently, miRNAs are commonly OPEN ACCESS encoded by viruses that undergo long-term persistent infection. Papillomaviruses (PVs) are Citation: Chirayil R, Kincaid RP, Dahlke C, Kuny capable of undergoing persistent infection, but as yet, no widely-accepted PV-encoded miR- CV, DaÈlken N, Spohn M, et al. (2018) Identification of virus-encoded microRNAs in divergent NAs have been described. The incomplete understanding of PV-encoded miRNAs is due in Papillomaviruses. PLoS Pathog 14(7): e1007156. part to lack of tractable laboratory models for most PV types. To overcome this, we have https://doi.org/10.1371/journal.ppat.1007156 developed miRNA Discovery by forced Genome Expression (miDGE), a new wet bench Editor: Paul Francis Lambert, University of approach to miRNA identification that screens numerous pathogen genomes in parallel. Wisconsin Madison School of Medicine and Public Using miDGE, we screened over 73 different PV genomes for the ability to code for miRNAs. Health, UNITED STATES Our results show that most PVs are unlikely to code for miRNAs and we conclusively dem- Received: April 4, 2018 onstrate a lack of PV miRNA expression in cancers associated with infections of several Accepted: June 15, 2018 high risk HPVs. However, we identified five different high-confidence or highly probable Published: July 26, 2018 miRNAs encoded by four different PVs (Human PVs 17, 37, 41 and a Fringilla coelebs PV (FcPV1)). Extensive in vitro assays confirm the validity of these miRNAs in cell culture and Copyright: © 2018 Chirayil et al. This is an open access article distributed under the terms of the two FcPV1 miRNAs are further confirmed to be expressed in vivo in a natural host. We Creative Commons Attribution License, which show that miRNAs from two PVs (HPV41 & FcPV1) are able to regulate viral transcripts cor- permits unrestricted use, distribution, and responding to the early region of the PV genome. Combined, these findings identify the first reproduction in any medium, provided the original canonical PV miRNAs and support that miRNAs of either host or viral origin are important author and source are credited. regulators of the PV life cycle. Data Availability Statement: The miDGE sequencing data are available via the European Nucleotide Archive (ENA, https://www.ebi.ac.uk/ ena) under accession number PRJEB25054. The sequencing data generated from chaffinch samples Author summary are available via the NCBI Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/sra) under the Papillomaviruses (PVs) are causative agents of cancer. Currently, there is an incomplete accession number SRP133175. understanding as to why only some infections lead to cancer. Developing a better compar- Funding: This work was supported by a Burroughs ative evolutionary understanding of PV gene products and their regulation is key to com- Wellcome Investigators in Pathogenesis Award and prehending the life cycle of these pathogens. An emerging concept of viral gene regulation a grant from the Cancer Prevention and Research PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007156 July 26, 2018 1 / 31 Large scale parallel identification of pathogen miRNAs Institute of Texas [RP140842] to CSS. AG is supported by the Free and Hanseatic City of is that many persistent viruses will utilize small regulatory RNAs called miRNAs to opti- Hamburg and the Federal Ministry of Health mize host and viral gene expression. Yet despite obvious interest, there have been no cred- (BMG). The funders had no role in study design, ible reports identifying canonical PV-encoded miRNAs. Here we develop new broadly data collection and analysis, decision to publish, or preparation of the manuscript. applicable methodology to identify miRNAs from organisms lacking a laboratory culture system. We identify the first examples of bona fide canonical PV miRNAs and provide Competing interests: The authors have declared evidence supporting both host and viral miRNA-mediated regulation as relevant to con- that no competing interests exist. trol of PV gene expression. These findings resolve the issue of PV miRNAs and further the notion of miRNA importance to persistent virus infection. Introduction Papillomaviruses (PVs) comprise a large family of circular double-stranded DNA viruses. Numerous PV genomes have been described including over 200 human PV (HPV) types. A minority of these are known as carcinogenic agents [1±3], however only a small fraction of hosts infected with these high risk types will go on to develop high grade lesions. It remains incompletely understood what factors dictate whether or not HPV infection will develop into malignant cancer [1,3]. Further, it is unclear why HPVs that share a high level of sequence sim- ilarity can have stark differences in tropism and infect different regions of the body. Develop- ing a better understanding of PV gene products and their regulation throughout diverse PV lineages provides an evolutionary foundation for deciphering the mechanisms resulting in dif- ferential outcomes of infection. MicroRNAs (miRNAs) are small regulatory RNAs that are an emerging class of viral gene products found in select virus families [4±7]. miRNAs are approximately 22 nucleotides long and function by docking to specific target mRNAs to repress translation [8,9]. miRNAs derive from primary transcripts containing a hairpin structure that is processed by a series of endo- nucleases (Drosha in the nucleus, Dicer in the cytosol) generating the final effector RNA [10± 15]. The miRNA then enters a multi-protein complex called the RNA Induced Silencing Com- plex (RISC) where it scans mRNAs and docks to regions of partial sequence complementarity [8]. The so-called seed region of miRNAs, approximately 6 or more nucleotides towards the 5' end, typically binds transcripts with perfect complementarity and this feature can be used to help identify mRNA targets [8,16,17]. miRNAs of a particular sequence typically function by subtly regulating numerous (10 or more) mRNA transcripts involved in a particular biological outcome. Although individual miRNA regulation of any single transcript can be subtle, the sum of regulation by multiple miRNA-bound-RISC complexes (miRISC) can add up to signifi- cant biological activity [8]. miRNAs of host or viral origin have been implicated in various pro- cesses relevant to virus infection including the control of the immune response, cell death, transformation and virus gene expression [18±29]. Over 300 viral encoded miRNAs have been described, all from viruses able to undergo long term persistent infection [4,5,7,30]. Most of these viruses have DNA genomes including the herpes, polyoma, and anello virus families [5]. However, some retroviruses including the delta retrovirus bovine leukemia virus (BLV) and foamy retroviruses also encode miRNAs [21,31± 33]. One likely role of viral miRNAs is to foster long-term interactions within the host [30]. In this regard, at least some members of the PV family would be expected to encode miRNAs. However, to date, no credible examples of PV canonical miRNAs have been described. Two studies examining fully infectious experimental systems of the high-risk HPV18 & 31 types report that these viruses do not encode miRNAs [34,35]. Further, at least two studies examin- ing transformed cell lines report that HPV16 does not encode miRNAs [36,37]. There have been reports in transformed cells of small RNAs from high risk PVs such as HPVs 16 & 18, PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007156 July 26, 2018 2 / 31 Large scale parallel identification of pathogen miRNAs however these studies did not demonstrate a connection of PV-derived small RNAs to the miRNA biogenesis (Dicer/Drosha) or effector (RISC) machinery, nor did they confirm a bio- logically meaningful abundance [38±40]. Consequently, these RNAs are not widely accepted as miRNAs and the signal detected likely represents degradation fragments derived from the turnover of longer transcripts. In contrast, it is well documented that PV infection and individ- ual PV gene products can alter the host miRNA repertoire, likely contributing to the biology of cancer [25,35,41±44]. Furthermore, at least one PV, HPV31, utilizes a host miRNA to directly regulate early viral gene expression [25]. Thus, what emerges is that although host miRNAs are involved in the PV life cycle and pathogenesis, of the few PV types that have been examined, no canonical PV miRNAs are yet established. One barrier to discovery of PV miRNAs is the dearth of facile fully-infectious laboratory systems. There are experimental systems established for a few PV types (approximately < 5) [45], but technological barriers have limited any comprehensive large-scale study of viral miR- NAs in the majority of PV types. Here we describe a new wet bench approach for the discovery of miRNAs that assays numerous viruses in parallel for the ability to express miRNAs. We identify bona fide PV miRNAs encoded by divergent PVs, and demonstrate these miRNAs depend on canonical miRNA biogenesis effector machinery. Our analysis also rules out canon- ical papillomaviral miRNAs in cancers associated with high-risk PV (HPVs 16, 18, 31, 45, and 58) infection. These results provide further evidence for the relevance of miRNA-mediated regulation of PV transcripts.
Load more

Recommended publications
  • Characterization of a Full-Length Infectious Clone of Bovine Foamy Virus 3026
    VIROLOGICA SINICA 2014, 29 (2): 94-102 DOI 10.1007/s12250-014-3382-5 RESEARCH ARTICLE Characterization of a full-length infectious clone of bovine foamy virus 3026 * Tiejun Bing1, Hong Yu1, 2, Yue Li1, Lei Sun3, Juan Tan1, Yunqi Geng1, Wentao Qiao1 1. Key Laboratory of Molecular Microbiology and Biotechnology (Ministry of Education) and Key Laboratory of Microbial Functional Genomics (Tianjin), College of Life Sciences, Nankai University, Tianjin 300071, China; 2. Department of Molecular and Cellular Pharmacology, the Vascular Biology Institute, University of Miami School of Medicine, Miami, FL 33136, USA; 3. National Laboratory of Biomacromolecules, Center for Biological Imaging, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China The biological features of most foamy viruses (FVs) are poorly understood, including bovine foamy virus (BFV). BFV strain 3026 (BFV3026) was isolated from the peripheral blood mononuclear cells of an infected cow in Zhangjiakou, China. A full-length genomic clone of BFV3026 was obtained from BFV3026-infected cells, and it exhibited more than 99% amino acid (AA) homology to another BFV strain isolated in the USA. Upon transfection into fetal canine thymus cells, the full-length BFV3026 clone produced viral structural and auxiliary proteins, typical cytopathic effects, and virus particles. These results demonstrate that the full-length BFV3026 clone is fully infectious and can be used in further BFV3026 research. KEYWORDS bovine foamy virus; infectious clone; syncytium; electron microscopy pol, and env structural genes and additional open read- INTRODUCTION ing frames (ORFs) that are under the control of the 5′- long terminal repeat (LTR) and an internal promoter (IP) Foamy viruses (FVs) are members of Retroviridae.
    [Show full text]
  • Foamy Virus Assembly with Emphasis on Pol Encapsidation
    Viruses 2013, 5, 886-900; doi:10.3390/v5030886 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Foamy Virus Assembly with Emphasis on Pol Encapsidation Eun-Gyung Lee 1, Carolyn R. Stenbak 2 and Maxine L. Linial 1,* 1 Fred Hutchinson Cancer Research Center, Basic Sciences Division; 1100 Fairview Avenue North, Seattle, WA 98109, USA; E-Mails: [email protected] (EGL); [email protected] (MLL) 2 Seattle University, Biology Department; 901 12th Avenue, Seattle, WA 98122, USA; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-206- 667-4442; Fax: +1-206-667-5939 Received: 31 January 2013; in revised form: 11 March 2013 / Accepted: 14 March 2013 / Published: 20 March 2013 Abstract: Foamy viruses (FVs) differ from all other genera of retroviruses (orthoretroviruses) in many aspects of viral replication. In this review, we discuss FV assembly, with special emphasis on Pol incorporation. FV assembly takes place intracellularly, near the pericentriolar region, at a site similar to that used by betaretroviruses. The regions of Gag, Pol and genomic RNA required for viral assembly are described. In contrast to orthoretroviral Pol, which is synthesized as a Gag-Pol fusion protein and packaged through Gag-Gag interactions, FV Pol is synthesized from a spliced mRNA lacking all Gag sequences. Thus, encapsidation of FV Pol requires a different mechanism. We detail how WT Pol lacking Gag sequences is incorporated into virus particles. In addition, a mutant in which Pol is expressed as an orthoretroviral-like Gag-Pol fusion protein is discussed.
    [Show full text]
  • D3.7 First Periodic Report on Ongoing Jrps WP3 Joint Research Projects
    D3.7 First periodic report on ongoing JRPs WP3 Joint Research Projects Responsible Partner: Sciensano Contributing partners: / 1 GENERAL INFORMATION European Joint Programme Promoting One Health in Europe through joint actions on foodborne full title zoonoses, antimicrobial resistance and emerging microbiological hazards European Joint Programme One Health EJP acronym Funding This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 773830. Grant Agreement Grant agreement n° 773830 Starting Date 01/01/2018 Duration 60 Months DOCUMENT MANAGEMENT Deliverable D3.7 First periodic report on ongoing JRPs WP and Task WP3; Task 3.2 Leader Sciensano Other contributors ANSES, SVA, WBVR, INSA Due month of the deliverable M13 Actual submission month M14 Type R R: Document, report DEC: Websites, patent fillings, videos, etc. OTHER Dissemination level PU PU: Public CO: confidential, only for members of the consortium (including the Commission Services) First periodic report on ongoing JRP Introduction Joint Research Projects serve as an instrument that help OneHealth EJP partners to work together in developing new detection methods, improved diagnostic tests, fast and accurate typing methods, in gaining new insight in the spread of pathogens and their resistance traits etc. At the same time, through setting up these scientific collaborations, researchers spread over Europe identify new possible partners and strengthen links between known colleagues. As such, the JRP help in creating and consolidating a firm network of organizations that have reference tasks in their scope and that deal with foodborne zoonoses, antimicrobial resistance and emerging threats. Summary of the performance of the Joint Research Projects Project deliverables and milestones The 11 joint research projects planned to submit a total of 77 deliverables.
    [Show full text]
  • Molecular Epidemiology and Whole-Genome Analysis of Bovine Foamy Virus in Japan
    viruses Article Molecular Epidemiology and Whole-Genome Analysis of Bovine Foamy Virus in Japan Hirohisa Mekata 1,* , Tomohiro Okagawa 2, Satoru Konnai 2,3 and Takayuki Miyazawa 4 1 Center for Animal Disease Control, University of Miyazaki, Miyazaki 889-2192, Japan 2 Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan; [email protected] (T.O.); [email protected] (S.K.) 3 Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan 4 Laboratory of Virus-Host Coevolution, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan; [email protected] * Correspondence: [email protected]; Tel./Fax: +81-985-58-7881 Abstract: Bovine foamy virus (BFV) is a member of the foamy virus family in cattle. Information on the epidemiology, transmission routes, and whole-genome sequences of BFV is still limited. To understand the characteristics of BFV, this study included a molecular survey in Japan and the determination of the whole-genome sequences of 30 BFV isolates. A total of 30 (3.4%, 30/884) cattle were infected with BFV according to PCR analysis. Cattle less than 48 months old were scarcely infected with this virus, and older animals had a significantly higher rate of infection. To reveal the possibility of vertical transmission, we additionally surveyed 77 pairs of dams and 3-month-old calves in a farm already confirmed to have BFV. We confirmed that one of the calves born from a dam with BFV was infected.
    [Show full text]
  • 10 International Foamy Virus Conference 2014
    10th INTERNATIONAL FOAMY VIRUS CONFERENCE 2014 June 24‐25, 2014 National Veterinary Research Institute, Pulawy, Poland Organized by: National Veterinary Research Institute Committee of Veterinary Sciences Polish Academy of Sciences Topics include: Foamy Virus Infection and Zoonotic Aspects, Foamy Virus Restriction and Immunity, Foamy Virus Biology and Gene Therapy Vectors http://www.piwet.pulawy.pl/ifvc/ Organizers Jacek Kuźmak and Magdalena Materniak Scientific Advisors Martin Löchelt and Axel Rethwilm Sponsors Support for the meeting was provided by the Committee of Veterinary Sciences Polish Academy of Sciences, ROCHE, Thermo Fisher Scientific and EURx Abstract book was issued thanks to the support provided by Committee of Veterinary Sciences Polish Academy of Sciences 2 Program Overview Monday, June 23rd, 2014 19 00 – 20 00 Registration 20 30 – open end Welcome Reception Tuesday, June 24th, 2014 9 00 – 9 30 Registration 9 30 – 9 45 Welcome 9 45 – 10 15 Arifa Khan (FDA, Bethesda, US) - Simian foamy virus infection in natural host species 10 15 – 10 45 Antoine Gessain (Institute Pasteur, Paris, France) – Zoonotic human infection by simian foamy viruses 10 45 – 11 20 Session 1 on Foamy Virus Infection and Zoonotic Aspects Chairs: Arifa S. Khan and Antoine Gessain 11 20 – 11 45 Coffee break 11 45 – 12 30 Session 1 on Foamy Virus Infection and Zoonotic Aspects Chairs: Arifa S. Khan and Antoine Gessain 12 30 – 13 00 Aris Katzourakis (Oxford University, UK - Mammalian genomes, their endogenous viral elements, and the evolutionary history
    [Show full text]
  • Important Role of N108 Residue in Binding of Bovine Foamy Virus
    Bing et al. Virology Journal (2016) 13:117 DOI 10.1186/s12985-016-0579-2 RESEARCH Open Access Important role of N108 residue in binding of bovine foamy virus transactivator Tas to viral promoters Tiejun Bing†, Suzhen Zhang†, Xiaojuan Liu, Zhibin Liang, Peng Shao, Song Zhang, Wentao Qiao and Juan Tan* Abstract Background: Bovine foamy virus (BFV) encodes the transactivator BTas, which enhances viral gene transcription by binding to the long terminal repeat promoter and the internal promoter. In this study, we investigated the different replication capacities of two similar BFV full-length DNA clones, pBS-BFV-Y and pBS-BFV-B. Results: Here, functional analysis of several chimeric clones revealed a major role for the C-terminal region of the viral genome in causing this difference. Furthermore, BTas-B, which is located in this C-terminal region, exhibited a 20-fold higher transactivation activity than BTas-Y. Sequence alignment showed that these two sequences differ only at amino acid 108, with BTas-B containing N108 and BTas-Y containing D108 at this position. Results of mutagenesis studies demonstrated that residue N108 is important for BTas binding to viral promoters. In addition, the N108D mutation in pBS-BFV-B reduced the viral replication capacity by about 1.5-fold. Conclusions: Our results suggest that residue N108 is important for BTas binding to BFV promoters and has a major role in BFV replication. These findings not only advances our understanding of the transactivation mechanism of BTas, but they also highlight the importance of certain sequence polymorphisms in modulating the replication capacity of isolated BFV clones.
    [Show full text]
  • Between Retroviruses and Pararetroviruses
    Virology 271, 1–8 (2000) doi:10.1006/viro.2000.0216, available online at http://www.idealibrary.com on MINIREVIEW Foamy Viruses: Between Retroviruses and Pararetroviruses Charles-Henri Lecellier and Ali Saı¨b 1 CNRS UPR9051, Universite´Paris 7, Hoˆpital Saint-Louis, 75475 Paris Cedex 10, France Received November 18, 1999; returned to author for revision December 14, 1999; accepted January 21, 2000 Foamy viruses, also called spumaviruses or spuma- sory proteins from the 3Ј end of the viral genome (Reth- retroviruses, are retroviruses described for the first time wilm et al., 1987). Construction of infectious clones of in 1954 in cell cultures derived from monkey kidneys HFV and cloning of viral genes out of the viral context (Enders et al., 1954). They are so named because of the allowed the study of the viral replication cycle and the specific cytopathic foam effect they induce in culture, implication of each gene product. One remarkable find- with the concomitant appearance of syncytia, facilitating ing is the striking similarity between FVs and the hepa- their isolation. In culture, FVs are highly lytic and present titis B virus (HBV, the prototype of hepadnaviruses) con- a large cellular tropism that reflects the ubiquity of the cerning the strategy used to replicate their genome (See- viral receptor (Hill et al., 1999). These viruses were ger et al., 1996). mainly isolated from primate species and also from non- The Third International Conference on Foamy Viruses, primates, such as cats (feline foamy virus [FeFV]) or held in Paris in June 1999, has brought new insights into cattle (bovine foamy virus [BFV]) and more recently from our understanding of these particular viruses, confirming horses (Tobaly-Tapiero et al., 1999) (Table 1).
    [Show full text]
  • 2002.V043.04: to Create Two Subfamilies Within the Family
    February 19, 2002 From the Retroviridae Study Group 2002.V043.04: To create two subfamilies within the family Retroviridae, the first one would contain the six genera as previously defined: Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Epsilonretrovirus and Lentivirus. The second one would contain a single genus, Spumavirus. 2002.V044.04: to name the first subfamily Orthoretrovirinae 2002.V045.04: to name the second subfamily Spumaretrovirinae. 2002.V046.04: To incorporate the genera Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Epsilonretrovirus and Lentivirus, currently genera of the family Retroviridae, within the new subfamily Spumaretrovirinae. 2002.V047.04: To incorporate the genus Spumavirus, currently a genus of the family Retroviridae, within the new subfamily Spumaretrovirinae. 2002.V048.04: To designate Simian foamy virus as the new type species of the genus Spumavirus instead of Champazee foamy virus, now a strain of the species Simian foamy virus. 2002.V049.04: To incorporate in the species Simian foamy virus, the new type species of the genus Spumavirus the strains Chimpanzee foamy virus, Simian foamy virus 1 and Simian foamy virus 3, previously listed as species in the Spumavirus genus _______________________________ 2002.V043.04: To create two subfamilies within the family Retroviridae, the first one would contain the six genera as previously defined: Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Epsilonretrovirus and Lentivirus. The second one would contain a single genus, Spumavirus. 2002.V044.04: to name the first subfamily Orthoretrovirinae 2002.V045.04: to name the second subfamily Spumaretrovirinae. Background: The background of this proposal is as follows: The Retroviridae Study Group had proposed in the past to separate the family Retroviridae into two subfamilies, to be called Orthoretrovirinae and the Spumaretrovirinae.
    [Show full text]
  • Isolation of an Equine Foamy Virus and Sero-Epidemiology of the Viral Infection in Horses in Japan
    viruses Article Isolation of an Equine Foamy Virus and Sero-Epidemiology of the Viral Infection in Horses in Japan Rikio Kirisawa 1,*, Yuko Toishi 2, Hiromitsu Hashimoto 3 and Nobuo Tsunoda 2 1 Laboratory of Veterinary Virology, Department of Pathobiology, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501, Japan 2 Shadai Stallion Station, Abira-cho, Hokkaido 059-1432, Japan 3 Shiraoi Farm, Shiraoi-cho, Hokkaido 059-0901, Japan * Correspondence: [email protected]; Tel.: +81-11-388-4748; Fax: +81-11-387-5890 Received: 10 June 2019; Accepted: 3 July 2019; Published: 5 July 2019 Abstract: An equine foamy virus (EFV) was isolated for the first time in Japan from peripheral blood mononuclear cells of a broodmare that showed wobbler syndrome after surgery for intestinal volvulus and the isolate was designated as EFVeca_LM. Complete nucleotide sequences of EFVeca_LM were determined. Nucleotide sequence analysis of the long terminal repeat (LTR) region, gag, pol, env, tas, and bel2 genes revealed that EFVeca_LM and the EFV reference strain had 97.2% to 99.1% identities. For a sero-epidemiological survey, indirect immunofluorescent antibody tests were carried out using EFVeca_LM-infected cells as an antigen against 166 sera of horses in five farms collected in 2001 to 2002 and 293 sera of horses in eight farms collected in 2014 to 2016 in Hokkaido, Japan. All of the farms had EFV antibody-positive horses, and average positive rates were 24.6% in sera obtained in 2001 to 2002 and 25.6% in sera obtained in 2014 to 2016 from broodmare farms.
    [Show full text]
  • The Effect of Bovine BST2A1 on the Release and Cell-To-Cell Transmission of Retroviruses
    Liang et al. Virology Journal (2017) 14:173 DOI 10.1186/s12985-017-0835-0 SHORT REPORT Open Access The effect of bovine BST2A1 on the release and cell-to-cell transmission of retroviruses Zhibin Liang1, Yang Zhang1, Jie Song1, Hui Zhang1, Suzhen Zhang1, Yue Li1, Juan Tan1 and Wentao Qiao1,2* Abstract Background: Human BST2 (hBST2, also called Tetherin) is a host restriction factor that blocks the release of various enveloped viruses. BST2s from different mammals also possess antiviral activity. Bovine BST2s (bBST2s), bBST2A1 and bBST2A2, reduce production of cell-free bovine leukemia virus (BLV) and vesicular stomatitis virus (VSV). However, the effect of bBST2 on other retroviruses remains unstudied. Results: Here, we studied the antiviral activity of wildtype and mutant bBST2A1 proteins on retroviruses including human immunodeficiency virus type 1 (HIV-1), prototypic foamy virus (PFV), bovine foamy virus (BFV) and bovine immunodeficiency virus (BIV). The results showed that wildtype bBST2A1 suppressed the release of HIV-1, PFV and BFV. We also generated bBST2A1 mutants, and found that GPI anchor and dimerization, but not glycosylation, are essential for antiviral activity of bBST2A1. Moreover, unlike hBST2, bBST2A1 displayed no inhibitory effect on cell-to-cell transmission of PFV, BFV and BIV. Conclusions: Our data suggested that bBST2A1 inhibited retrovirus release, however, had no effect on cell-to-cell transmission of retroviruses. Keywords: bBST2A1, HIV-1, PFV, BFV, BIV, Virus release, Cell-to-cell transmission Background BST2 also inhibits the release of other enveloped Bone marrow stromal cell antigen 2 (BST2, also called viruses, including simian immunodeficiency virus (SIV) tetherin) blocks the release of vpu-deficient human im- [13], murine leukemia virus (MLV) [11], Lassa virus and munodeficiency virus type 1 (HIV-1) [26, 32] by directly Marburg virus [29], Ebola virus [17, 18], Kaposi’s tethering the viral particles to the cell surface [28].
    [Show full text]
  • Palmitoylation of the Bovine Foamy Virus Envelope Glycoprotein Is Required for Viral Replication
    viruses Article Palmitoylation of the Bovine Foamy Virus Envelope Glycoprotein Is Required for Viral Replication Keli Chai, Zhaohuan Wang, Yali Xu, Junshi Zhang, Juan Tan and Wentao Qiao * Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China; [email protected] (K.C.); [email protected] (Z.W.); [email protected] (Y.X.); [email protected] (J.Z.); [email protected] (J.T.) * Correspondence: [email protected]; Tel.: +86-22-2350-4547; Fax: +86-22-2350-0950 Abstract: Membrane proteins of enveloped viruses have been reported to undergo palmitoylation, a post-translational modification often having a critical role in the function of these viral proteins and hence viral replication. In this study, we report that the foamy virus (FV) envelope (Env) glycoprotein is palmitoylated. Specifically, we found that bovine foamy virus (BFV) Env (BEnv) is palmitoylated at amino acid positions C58 and C59 by BDHHC3 and BDHHC20 in a DHHC motif-dependent manner. In addition, mutations C58S and C58/59S significantly decrease cell surface expression of BEnv, subviral particle (SVP) egress, and its membrane fusion activity, thus ultimately inhibiting BFV replication. The C59S mutation exerts a minor effect in this regard. Taken together, these data demonstrate that the function of BEnv in the context of BFV replication is under the regulation of palmitoylation. Keywords: bovine foamy virus; envelope glycoprotein; palmitoylation; BDHHC3; BDHHC20; mem- brane fusion; subviral particle; cell surface; replication Citation: Chai, K.; Wang, Z.; Xu, Y.; Zhang, J.; Tan, J.; Qiao, W.
    [Show full text]
  • Infection with Foamy Virus in Wild Ruminants—Evidence for a New Virus Reservoir?
    viruses Article Infection with Foamy Virus in Wild Ruminants—Evidence for a New Virus Reservoir? Magdalena Materniak-Kornas 1,*, Martin Löchelt 2, Jerzy Rola 3 and Jacek Ku´zmak 1 1 Department of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland; [email protected] 2 German Cancer Research Center DKFZ, Program Infection, Inflammation and Cancer, Division of Viral Transformation Mechanisms, 69120 Heidelberg, Germany; [email protected] 3 Department of Virology, National Veterinary Research Institute, 24-100 Pulawy, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-81-889-3116 Received: 18 October 2019; Accepted: 31 December 2019; Published: 3 January 2020 Abstract: Foamy viruses (FVs) are widely distributed and infect many animal species including non-human primates, horses, cattle, and cats. Several reports also suggest that other species can be FV hosts. Since most of such studies involved livestock or companion animals, we aimed to test blood samples from wild ruminants for the presence of FV-specific antibodies and, subsequently, genetic material. Out of 269 serum samples tested by ELISA with the bovine foamy virus (BFV) Gag and Bet antigens, 23 sera showed increased reactivity to at least one of them. High reactive sera represented 30% of bison samples and 7.5% of deer specimens. Eleven of the ELISA-positives were also strongly positive in immunoblot analyses. The peripheral blood DNA of seroreactive animals was tested by semi-nested PCR. The specific 275 bp fragment of the pol gene was amplified only in one sample collected from a red deer and the analysis of its sequence showed the highest homology for European BFV isolates.
    [Show full text]